63 related articles for article (PubMed ID: 9529622)
1. Endogenous digitalis: pathophysiologic roles and therapeutic applications.
Bagrov AY; Shapiro JI
Nat Clin Pract Nephrol; 2008 Jul; 4(7):378-92. PubMed ID: 18542120
[TBL] [Abstract][Full Text] [Related]
2. How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.
Blaustein MP; Leenen FH; Chen L; Golovina VA; Hamlyn JM; Pallone TL; Van Huysse JW; Zhang J; Wier WG
Am J Physiol Heart Circ Physiol; 2012 Mar; 302(5):H1031-49. PubMed ID: 22058154
[TBL] [Abstract][Full Text] [Related]
3. The cardiac glycoside binding site on the Na,K-ATPase alpha2 isoform plays a role in the dynamic regulation of active transport in skeletal muscle.
Radzyukevich TL; Lingrel JB; Heiny JA
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2565-70. PubMed ID: 19196986
[TBL] [Abstract][Full Text] [Related]
4. Ouabain-Sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load.
Loreaux EL; Kaul B; Lorenz JN; Lingrel JB
J Am Soc Nephrol; 2008 Oct; 19(10):1947-54. PubMed ID: 18667729
[TBL] [Abstract][Full Text] [Related]
5. Cardiac steroids induce changes in recycling of the plasma membrane in human NT2 cells.
Rosen H; Glukhman V; Feldmann T; Fridman E; Lichtstein D
Mol Biol Cell; 2004 Mar; 15(3):1044-54. PubMed ID: 14718569
[TBL] [Abstract][Full Text] [Related]
6. Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent.
Sophocleous A; Elmatzoglou I; Souvatzoglou A
J Endocrinol Invest; 2003 Jul; 26(7):668-74. PubMed ID: 14594120
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of Na+, K+-ATPase inhibition by an endogenous modulator (II-A).
Reinés A; Peña C; Rodríguez de Lores Arnaiz G
Neurochem Res; 2000 Jan; 25(1):121-7. PubMed ID: 10685611
[TBL] [Abstract][Full Text] [Related]
8. On the structure of endogenous ouabain.
Kawamura A; Guo J; Itagaki Y; Bell C; Wang Y; Haupert GT; Magil S; Gallagher RT; Berova N; Nakanishi K
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6654-9. PubMed ID: 10359767
[TBL] [Abstract][Full Text] [Related]
9. Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human.
Balzan S; Montali U; Ghione S
Ann N Y Acad Sci; 1997 Nov; 834():626-30. PubMed ID: 9405875
[No Abstract] [Full Text] [Related]
10. Ouabain-like factor.
Goto A; Yamada K
Curr Opin Nephrol Hypertens; 1998 Mar; 7(2):189-96. PubMed ID: 9529622
[TBL] [Abstract][Full Text] [Related]
11. Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
Haddy FJ; Pamnani MB
Clin Exp Hypertens; 1998; 20(5-6):499-508. PubMed ID: 9682906
[TBL] [Abstract][Full Text] [Related]
12. Putative roles of ouabainlike compound in hypertension: revisited.
Goto A; Yamada K
Hypertens Res; 2000 Sep; 23 Suppl():S7-13. PubMed ID: 11016813
[TBL] [Abstract][Full Text] [Related]
13. Ouabain-like factor: is this the natriuretic hormone?
Ferrandi M; Manunta P
Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):165-71. PubMed ID: 10757222
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
Meyer-Lehnert H; Bäcker A; Kramer HJ
Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
